15-101177985-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_014918.5(CHSY1):c.1812G>A(p.Val604Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0154 in 1,614,176 control chromosomes in the GnomAD database, including 335 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.016 ( 31 hom., cov: 33)
Exomes 𝑓: 0.015 ( 304 hom. )
Consequence
CHSY1
NM_014918.5 synonymous
NM_014918.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.25
Publications
5 publications found
Genes affected
CHSY1 (HGNC:17198): (chondroitin sulfate synthase 1) This gene encodes a member of the chondroitin N-acetylgalactosaminyltransferase family. These enzymes possess dual glucuronyltransferase and galactosaminyltransferase activity and play critical roles in the biosynthesis of chondroitin sulfate, a glycosaminoglycan involved in many biological processes including cell proliferation and morphogenesis. Decreased expression of this gene may play a role in colorectal cancer, and mutations in this gene are a cause of temtamy preaxial brachydactyly syndrome. [provided by RefSeq, Dec 2011]
CHSY1 Gene-Disease associations (from GenCC):
- temtamy preaxial brachydactyly syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 15-101177985-C-T is Benign according to our data. Variant chr15-101177985-C-T is described in ClinVar as Benign. ClinVar VariationId is 466170.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.25 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0627 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CHSY1 | NM_014918.5 | c.1812G>A | p.Val604Val | synonymous_variant | Exon 3 of 3 | ENST00000254190.4 | NP_055733.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CHSY1 | ENST00000254190.4 | c.1812G>A | p.Val604Val | synonymous_variant | Exon 3 of 3 | 1 | NM_014918.5 | ENSP00000254190.3 | ||
| CHSY1 | ENST00000543813.2 | n.*1127G>A | non_coding_transcript_exon_variant | Exon 3 of 3 | 2 | ENSP00000496160.1 | ||||
| CHSY1 | ENST00000543813.2 | n.*1127G>A | 3_prime_UTR_variant | Exon 3 of 3 | 2 | ENSP00000496160.1 |
Frequencies
GnomAD3 genomes AF: 0.0162 AC: 2459AN: 152196Hom.: 31 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
2459
AN:
152196
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0242 AC: 6094AN: 251438 AF XY: 0.0224 show subpopulations
GnomAD2 exomes
AF:
AC:
6094
AN:
251438
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0153 AC: 22323AN: 1461862Hom.: 304 Cov.: 37 AF XY: 0.0150 AC XY: 10877AN XY: 727226 show subpopulations
GnomAD4 exome
AF:
AC:
22323
AN:
1461862
Hom.:
Cov.:
37
AF XY:
AC XY:
10877
AN XY:
727226
show subpopulations
African (AFR)
AF:
AC:
136
AN:
33480
American (AMR)
AF:
AC:
2419
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
804
AN:
26132
East Asian (EAS)
AF:
AC:
2247
AN:
39700
South Asian (SAS)
AF:
AC:
1065
AN:
86256
European-Finnish (FIN)
AF:
AC:
1461
AN:
53418
Middle Eastern (MID)
AF:
AC:
65
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
13024
AN:
1111992
Other (OTH)
AF:
AC:
1102
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1411
2821
4232
5642
7053
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
550
1100
1650
2200
2750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0162 AC: 2463AN: 152314Hom.: 31 Cov.: 33 AF XY: 0.0173 AC XY: 1286AN XY: 74488 show subpopulations
GnomAD4 genome
AF:
AC:
2463
AN:
152314
Hom.:
Cov.:
33
AF XY:
AC XY:
1286
AN XY:
74488
show subpopulations
African (AFR)
AF:
AC:
244
AN:
41564
American (AMR)
AF:
AC:
539
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
89
AN:
3472
East Asian (EAS)
AF:
AC:
355
AN:
5180
South Asian (SAS)
AF:
AC:
81
AN:
4824
European-Finnish (FIN)
AF:
AC:
280
AN:
10618
Middle Eastern (MID)
AF:
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
AC:
833
AN:
68036
Other (OTH)
AF:
AC:
37
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
116
232
347
463
579
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
123
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 09, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oct 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Temtamy preaxial brachydactyly syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.